drugset / Trial / NCT00630786
Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study
NaSingle-groupOpen-labelTreatment
Summary
This is an exploratory phase 1b/2, global, multicenter, single-arm, 2-part (phase 1b and 2) study of conatumumab in combination with panitumumab in patients with Metastatic Colorectal Cancer.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-05
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Conatumumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Subject | Panitumumab | Monoclonal antibody | 6 mg/kg | Intravenous |